Home' Australian Pharmacist : Australian Pharmacist May 2013 Contents 14 Australian Pharmacist May 2013 I ©Pharmaceutical Society of Australia Ltd.
PSA ethics advisory pilot
PSA has beefed up its Code of ethics for
pharmacists with the launch of an Ethics
Advisory Service (EAS).
The pilot service will provide information
and advice to PSA members and act on
complaints from members.
The new service, which is available free-of-
charge to PSA members, is based on PSA's
Code of Ethics for Pharmacists which consists
of principles covering five areas which are
core to pharmacists and pharmacy practice.
These are: the consumer, the community, the
pharmacy profession, business practices and
other health-care professionals. The Code
has been endorsed by the Pharmacy Board
PSA National President Grant Kardachi,
said the pilot run for 18 months with an
evaluation at the end.
He said that the new service was developed
following discussions with other peak
pharmacy organisations to ensure that it
complements existing services.
'PSA has engaged in high-level discussions
with a number of key stakeholders all of
whom have agreed that the Ethics Advisory
Service will be of benefit to the profession
and be widely welcomed.
"PSA's Ethics Advisory Service will operate
alongside -- and in no way seek to replace
-- existing services provided by other key
organisations. These include the Pharmacy
Board of Australia the Pharmacists' Support
Service and Pharmaceutical Defence Limited.'
Mr Kardachi said the new service will
not accept inquiries or complaints that
are the professional responsibility of a
pharmacist to report to the Pharmacy
Board of Australia under its Guidelines for
'Our new service does not replace the
professional responsibilities of pharmacists
in reporting certain matters to the Board.
A key element of the new service is an Ethics
Advisory Panel made up of a committee of
experts who will offer advice and assistance
to PSA members with an inquiry or
complaint. The panel will advise members
who have questions over ethical dilemmas
or potential breaches of the Code of Ethics.
The EAS can be accessed via: www.psa.org.au
NZ not ideal model
NZ's model of medicines delivery,
praised in the Grattan Report as
an example that Australia should
follow, was flawed and did not give
consumers the health benefits enjoyed
under the Australian system, President
of the National Pharmaceutical
Services Association Patrick Davies
said. He said the report had simply
cherry-picked issues and did not look
at the full picture. 'For instance it
does not look at the whole generics
situation, nor does it take into account
price cuts under price disclosure. In NZ
their health outcomes in areas such as
cardiovascular are much worse than
we see in Australia. Consumers can
wait up to three years for medicines in
P zer stands rm
Pfizer Direct is moving towards its one
millionth delivery and the system has
been a resounding success, according
to Jenny Alltoft, Head of Established
Products Australia/New Zealand at
Pfizer. 'We have completed 950,000
deliveries with 99% of deliveries being
on time. This system is nothing that we
have plans to move away from,' she said.
S3: use them or lose them
Pharmacists needed to maintain
a strong focus on S3 products,
pharmacist Nick Logan said in his
address, Why S3 is better for business,
better for customers and better for
you. Mr Logan alluded to what he
described as S3 fatigue, which he
said was a 'disease that can cripple
your pharmacy if left unchecked'.
To overcome this fatigue, he said
specialised S3 training was needed.
'It is important that we become
educators in the use of S3 medicines,
not gate-keepers.' He also warned
of the danger of a 'use them or lose
them' situation occurring over S3. 'It is
absolutely essential we embrace S2
and S3, otherwise we will lose them,'
HMRs under re
Homes Medicines Reviews were rife with
rorts and the system needed major change,
National President of the Pharmacy Guild
Kos Sclavos said.
'There are huge rorts. I stand by the claim,'
Mr Sclavos said.
'I have had correspondence from
pharmacists saying nothing is wrong with
them but the Minister would not have
changed the system if nothing was wrong.'
He cited the case of one pharmacist who
'squatted' inside a medical centre and who
thought the Guild was endorsing some of
the practices where there 'is $80 to $100
kickbacks. So the doctors already get over
$150 to do their HMR and the pharmacist,
in return for rent, pays $80--$100 per HMR.
'That's just a rort. If it was rent it would be
the same amount each week or month; if it
was a rent there would be a lease. There are
Mr Sclavos said the old rules for delivering
HMRs were unequivocal. The old rules
stated: 'The patient interview must occur
face-to-face at the patient's home except in
'Does anything think that is ambiguous?
There's nothing ambiguous about the old
rule. We have to address this.'
Guild the 'only negotiator'
Suggestions any other groups were
involved in negotiations for Community
Pharmacy Agreements were wrong and the
Guild is the 'only negotiator'.
This was the message from the National
President of the Pharmacy Guild, Kos
Sclavos, to APP delegates.
'Let me assure you, the Guild's situation is
that we fought very hard for the professional
fees [in the Agreement],' he said.
'We negotiated for them. No one else
negotiates for them. Don't believe the
press. The only negotiator is the Guild
and the Guild's position is that things
[regarding HMRs] have to change.
'It's embarrassing for a supporter of
pharmacy like Minister [Tanya] Plibersek to
get correspondence on this issue.
'If anyone thinks a politician works well
with threats and the fact it's an election
this year they are wrong.'
Links Archive Australian Pharmacist April 2013 Australian Pharmacist June 2013 Navigation Previous Page Next Page